BioVie Inc. (BIVI) Insider Trading Activity

NASDAQ$1.32-0.41 (-23.70%)
Market Cap
$15.02M
Sector
Healthcare
Industry
Biotechnology
Rank in Sector
327 of 849
Rank in Industry
187 of 491

BIVI Insider Trading Activity

BIVI Median Price and Trade Amounts History Chart

Statistics of Insider Transactions

Amount of Insider Buys and Sells

Buys
$49,118
4
100
Sells
$0
0
0

Related Transactions

DO CUONG VPresident & CEO
1
$31,637
0
$0
$31,637
Palumbo Joseph MChief Medical Officer
1
$10,461
0
$0
$10,461
KIM JOANNE WENDYChief Financial Officer
1
$5,450
0
$0
$5,450
Chappell Amy Suzondirector
1
$1,570
0
$0
$1,570

About BioVie Inc.

BioVie Inc. is a clinical-stage biotechnology firm primarily dedicated to the discovery, development, and commercialization of innovative drug treatments across the United States. The company's developmental portfolio includes BIV201, a therapeutic agent that has successfully completed its Phase IIa clinical trial for addressing ascites resulting from chronic liver cirrhosis. Additionally, BioVie is advancing NE3107, which is currently undergoing a Phase III clinical trial for the management of mild to moderate Alzheimer's disease, and is also …

Insider Activity of BioVie Inc.

Over the last 12 months, insiders at BioVie Inc. have bought $49,118 and sold $0 worth of BioVie Inc. stock.

On average, over the past 5 years, insiders at BioVie Inc. have bought $21,929 and sold $176,352 worth of stock each year.

Highest buying activity among insiders over the last 12 months: DO CUONG V (President & CEO) — $31,637. Palumbo Joseph M (Chief Medical Officer) — $10,461. KIM JOANNE WENDY (Chief Financial Officer) — $5,450.

The last purchase of 4,843 shares for transaction amount of $10,461 was made by Palumbo Joseph M (Chief Medical Officer) on 2026‑08‑28.

List of Insider Buy and Sell Transactions, BioVie Inc.

2026-08-28PurchasePalumbo Joseph MChief Medical Officer
4,843
0.0642%
$2.16
$10,461
-30.79%
2026-08-28PurchaseKIM JOANNE WENDYChief Financial Officer
2,500
0.0335%
$2.18
$5,450
-30.79%
2026-08-28PurchaseChappell Amy Suzondirector
727
0.0096%
$2.16
$1,570
-30.79%
2026-08-27PurchaseDO CUONG VPresident & CEO
15,210
0.1915%
$2.08
$31,637
-30.59%
2025-08-07PurchaseDO CUONG VPresident & CEO
5,000
–
$0
$0
-48.45%
2024-03-04PurchaseDO CUONG VPresident & CEO
10,000
0.0236%
$1.00
$10,000
-71.31%
2023-12-01SaleGORLIN STEVEdirector
75,680
0.2029%
$1.69
$127,899
-72.15%
2023-11-30PurchaseDO CUONG VPresident & CEO
10,000
0.0263%
$1.78
$17,800
-73.92%
2023-09-05SaleGORLIN STEVEdirector
8,560
0.023%
$3.05
$26,108
-74.26%
2023-08-22SaleBERMAN RICHARD Jdirector
10,805
0.0289%
$3.50
$37,827
-70.51%
2023-06-07SaleBERMAN RICHARD Jdirector
5,984
0.017%
$5.81
$34,782
-69.90%
2023-05-22SaleBERMAN RICHARD Jdirector
5,000
0.0137%
$6.50
$32,506
-54.90%
2023-03-28SaleBERMAN RICHARD Jdirector
7,613
0.0213%
$8.52
$64,870
-59.33%
2023-03-27SaleBERMAN RICHARD Jdirector
3,371
0.0096%
$8.52
$28,711
-58.32%
2021-12-07PurchaseKIM JOANNE WENDYCFO
2,000
0.0084%
$5.40
$10,798
-38.99%
2020-11-03PurchaseGORLIN STEVEdirector
2,430
0.0171%
$7.95
$19,319
+78.22%
2020-10-30PurchaseGORLIN STEVEdirector
2,570
0.0185%
$7.97
$20,483
+81.68%
2020-10-21PurchaseGORLIN STEVEdirector
5,000
0.0362%
$9.19
$45,950
+58.95%
2020-10-15PurchaseGORLIN STEVEdirector
15,100
0.1065%
$10.10
$152,517
+40.72%
2020-10-09PurchaseGORLIN STEVEdirector
282
0.002%
$9.61
$2,710
+50.83%
Total: 22
*Gray background shows transactions not older than one year

BIVI Institutional Investors: Active Positions

Increased Positions13+33.33%466,199+44.23%
Decreased Positions13-33.33%217,200-20.61%
New Positions8New347,464New
Sold Out Positions3Sold Out151Sold Out
Total Postitions390%1M+23.62%

BIVI Ownership Change vs Market

Institutional Investor Ownership

Top Shareholders
Top Buyers
Top Sellers
New Shareholders
Sold-Out Shareholders
Active Shareholders
Diametric Capital, Lp$492.004.63%370,000+370,000New2025-09-30
Prelude Capital Management, Llc$193.001.81%144,762+144,762New2025-09-30
Prosperity Wealth Management, Inc.$191.001.79%143,500+143,500New2025-09-30
Vanguard Group Inc$171.001.61%128,932+73,695+133.42%2025-09-30
Citadel Advisors Llc$139.001.31%104,531+104,531New2025-09-30
Philadelphia Trust Co$100.000.94%75,010+75,010New2025-09-30
Renaissance Technologies Llc$97.000.91%72,918+72,918New2025-09-30
Geode Capital Management, Llc$70.000.66%52,374+38,434+275.71%2025-09-30
Squarepoint Ops Llc$44.000.42%33,294+33,294New2025-09-30
Two Sigma Investments, Lp$43.000.41%32,505+32,505New2025-09-30

Financial Ratios

Summary
Comparison with Competitors

Price to Earnings

Price/Earnings to Growth

Price to Sales

Price to Book

Price/Free Cash Flow

Analyst Recommendations

Analyst Price Targets

No data is available at this moment.
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.